标题
Stereotactic radiosurgery and immunotherapy for metastatic spinal melanoma
作者
关键词
-
出版物
Neurosurgical Focus
Volume 38, Issue 3, Pages E6
出版商
Journal of Neurosurgery Publishing Group (JNSPG)
发表日期
2015-03-02
DOI
10.3171/2014.11.focus14716
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Stereotactic radiosurgery: A new paradigm for melanoma and renal cell carcinoma spine metastases.
- (2017) A. Thiagaragan et al. JOURNAL OF CLINICAL ONCOLOGY
- The use of stereotactic radiosurgery for the treatment of spinal axis tumors: A review
- (2014) Mohamad Bydon et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Radiobiological basis of SBRT and SRS
- (2014) Chang W. Song et al. International Journal of Clinical Oncology
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Latest Advances in Chemotherapeutic, Targeted, and Immune Approaches in the Treatment of Metastatic Melanoma
- (2014) Darshil J. Shah et al. MAYO CLINIC PROCEEDINGS
- Spine radiosurgery for spinal metastases: indications, technique and outcome
- (2014) Ran Harel et al. NEUROLOGICAL RESEARCH
- Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis
- (2014) Matthias Guckenberger et al. Radiation Oncology
- Stereotactic radiosurgery in the treatment of brain metastases: The current evidence
- (2013) Bodo Lippitz et al. CANCER TREATMENT REVIEWS
- Local disease control for spinal metastases following “separation surgery” and adjuvant hypofractionated or high-dose single-fraction stereotactic radiosurgery: outcome analysis in 186 patients
- (2013) Ilya Laufer et al. JOURNAL OF NEUROSURGERY-SPINE
- High intensity focused ultrasound ablation and antitumor immune response
- (2013) Feng Wu JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA
- Vertebral compression fracture after stereotactic body radiotherapy for spinal metastases
- (2013) Arjun Sahgal et al. LANCET ONCOLOGY
- The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma
- (2013) Howard L. Kaufman et al. Nature Reviews Clinical Oncology
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- The NOMS Framework: Approach to the Treatment of Spinal Metastatic Tumors
- (2013) I. Laufer et al. ONCOLOGIST
- The Human Melanoma Side Population Displays Molecular and Functional Characteristics of Enriched Chemoresistance and Tumorigenesis
- (2013) Jasper Wouters et al. PLoS One
- Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
- (2013) M. P. O'Connell et al. Cancer Discovery
- CTLA-4 Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma
- (2012) P. A. Prieto et al. CLINICAL CANCER RESEARCH
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
- (2012) Suzanne L Topalian et al. CURRENT OPINION IN IMMUNOLOGY
- Stereotactic Body Radiation Therapy in Spinal Metastases
- (2012) Kamran A. Ahmed et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
- (2012) Jonathan P. S. Knisely et al. JOURNAL OF NEUROSURGERY
- Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
- (2012) Eva Ellebaek et al. Journal of Translational Medicine
- Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
- (2012) Georgina V Long et al. LANCET ONCOLOGY
- Increasing Incidence of Melanoma Among Young Adults: An Epidemiological Study in Olmsted County, Minnesota
- (2012) Kurtis B. Reed et al. MAYO CLINIC PROCEEDINGS
- Vemurafenib: the first drug approved for BRAF-mutant cancer
- (2012) Gideon Bollag et al. NATURE REVIEWS DRUG DISCOVERY
- Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
- (2012) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Malignant melanoma and radiotherapy: past myths, excellent local control in 146 studied lesions at Georgetown University, and improving future management
- (2012) Pooya Jahanshahi et al. Frontiers in Oncology
- White Paper on Adoptive Cell Therapy for Cancer with Tumor-Infiltrating Lymphocytes: A Report of the CTEP Subcommittee on Adoptive Cell Therapy
- (2011) J. Weber et al. CLINICAL CANCER RESEARCH
- Immunomodulatory cytokines as therapeutic agents for melanoma
- (2011) Courtney Nicholas et al. Immunotherapy
- Establishment and Large-scale Expansion of Minimally cultured “Young” Tumor Infiltrating Lymphocytes for Adoptive Transfer Therapy
- (2011) Orit Itzhaki et al. JOURNAL OF IMMUNOTHERAPY
- Safety and clinical activity of ipilimumab in melanoma patients with brain metastases
- (2011) Jeffrey S. Weber et al. MELANOMA RESEARCH
- Systematic Review of Medical Treatment in Melanoma: Current Status and Future Prospects
- (2011) C. Garbe et al. ONCOLOGIST
- Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study
- (2010) S. J. O'Day et al. ANNALS OF ONCOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Interferon-β-1b
- (2010) Greg L. Plosker CNS DRUGS
- Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline
- (2010) Milan J. Sonneveld et al. HEPATOLOGY
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- En Bloc Resection for Primary and Metastatic Tumors of the Spine
- (2010) Jordan M. Cloyd et al. NEUROSURGERY
- Fractionated but Not Single-Dose Radiotherapy Induces an Immune-Mediated Abscopal Effect when Combined with Anti-CTLA-4 Antibody
- (2009) M. Z. Dewan et al. CLINICAL CANCER RESEARCH
- Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation
- (2009) A. Carpi et al. CURRENT CANCER DRUG TARGETS
- Melanoma-induced brain metastases
- (2008) Robert R McWilliams et al. Expert Review of Anticancer Therapy
- Stereotactic Body Radiosurgery for Spinal Metastases: A Critical Review
- (2008) Arjun Sahgal et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- High-Dose, Single-Fraction Image-Guided Intensity-Modulated Radiotherapy for Metastatic Spinal Lesions
- (2008) Yoshiya Yamada et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Neuropsychiatric disorders related to interferon and interleukins treatment
- (2008) Aye Mu Myint et al. METABOLIC BRAIN DISEASE
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity
- (2008) J. Tsai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS
- (2008) F Stephen Hodi et al. Nature clinical practice. Oncology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now